A Proof of Concept Study for Preemptive Treatment With Grazoprevir and Elbasvir in Donor HCV-positive to Recipient HCV-negative Cardiac Transplant
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Proof of concept; Therapeutic Use
- 04 Oct 2017 Status changed from not yet recruiting to suspended.
- 11 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 1 Dec 2017.
- 27 Apr 2017 Planned initiation date changed from 1 Apr 2017 to 1 Jul 2017.